The Serum Institute of India has demanded Rs 100 crore as damages to its reputation in a defamation suit after a Chennai-based volunteer served a legal notice to the Serum Institute of India (SII) demanding Rs 5 crore compensation for the alleged neurological complications he developed after being administered a test dose of its Covidshield vaccine.

Serum Institute of India rejects charges by ‘Covishield’ volunteer, threatens to seek Rs 100 cr damages

Coronavirus vaccine trials are going on in India and across the world and the race for the vaccine is in the last leg. India is a key player in global fight against coronavirus pandemic.

COVID-19 vaccine will be distributed in India initially, Serum Institute reiterates

Prime Minister Narendra Modi on Saturday, visited Bharat Biotech, a Hyderabad-based Pharmaceutical company to know about the progress made in the development of indigenous coronavirus vaccine.

Bharat Biotech working with ICMR for speedy progress on vaccine: PM Modi

Reports claim India's Prime Minister Narendra Modi will visit The Serum Institute of India on Nov 28. Why is this visit so important for India and the Developing World?

Gravitas: Biggest vaccine stories of the day

Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.

India's Serum says made 40 million doses of AstraZeneca's COVID-19 vaccine

Serum Insitute of India, the world's largest maker of vaccines, on Thursday said it has already produced 40 million doses of AstraZeneca's potential COVID-19 vaccine.

India's Serum Institute, world's largest vaccine maker says 40 million doses of AstraZeneca drug produced

Bangladesh has signed a crucial deal with the Serum Institute of India to acquire 30 million doses of a potential vaccine being developed by AstraZeneca for COVID-19.

COVID-19 vaccine: Bangladesh signs deal with Serum Institute of India

Oxford is developing a COVID-19 vaccine with Serum Institute of India, and as the trials further, the CEO Adar Poonawalla has claimed that the vaccine will be available till the end of the year.

Oxford's COVID-19 vaccine will be ready by December: Serum Institute CEO Adar Poonawalla

Drugs Controller General of India (DGCI) has issued a show-cause notice to Serum Institute, the world's third largest vaccine manufacturer over safety issues in COVID-19 vaccine trials.

Why haven't COVID-19 vaccine trials stopped? DCGI asks Serum Institute over safety concerns

Serum Institute, the Pune-based third largest manufacturer of vaccines in the world has said that it will continue with Covid-19 vaccine trials in India. Serum Institute said that they had not faced any issues.

Oxford University Covid-19 vaccine trials in India to continue despite 'pause' in UK: Serum Institute

Bangladesh`s Beximco Pharmaceuticals is investing in the Serum Institute of India (SII) to ensure Dhaka gets priority access to COVID-19 vaccines being developed by the Indian drug manufacturer, the company said on Friday.

Bangladesh's Beximco signs COVID-19 vaccine deal with India's Serum Institute

Serum Institute of India said on Friday it would receive $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make 100 million COVID-19 vaccine doses for India and other emerging economies as early as 2021.

Serum Institute to get $150 million from Gates Foundation for COVID-19 vaccine

serum-institute

Serum Institute, News on Serum Institute, stories on Serum Institute, articles on Serum Institute, Serum Institute stories at Wion, Serum Institute news, Serum Institute latest news

serum institute